Expression of angiogenic growth factors in laryngeal carcinoma

Korampalli,Tirupati  S.; Stafford,Nicholas D.

doi:10.3892/mco.2013.179

Expression of angiogenic growth factors in laryngeal carcinoma

Authors:
- Tirupati S. Korampalli
- Nicholas D. Stafford
View Affiliations

Affiliations: Postgraduate Medical Institute, University of Hull, Castle Hill Hospital, Cottingham, Hull HU16 5JQ, UK
Published online on: September 12, 2013 https://doi.org/10.3892/mco.2013.179
Pages: 1013-1018

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

over 2,200 cases of carcinoma of the larynx are diagnosed in the UK annually, with an overall 5‑year survival rate of 67%. Angiogenesis is vital for the growth and metastasis of solid tumours and the expression of key angiogenesis‑related proteins has been shown to be of prognostic significance. In this study we reported the expression of key angiogenesis‑related factors, selected from a pilot array study, in a cohort of laryngeal tumours and associated metastatic lymph nodes. Forty patients diagnosed with squamous cell carcinoma of the larynx were recruited. Tissue specimens were obtained intra‑operatively, prior to chemo- and/or radiotherapy, from the tumours and secondary lymph nodes. The patient group comprised 32 men and 8 women with a mean age of 68 years (range, 51‑89 years). The relative expression of the angiogenesis‑related proteins angiogenin, interleukin (IL)‑8, tissue inhibitor of metalloproteinases‑1 (TIMP‑1), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF)‑basic and insulin-like growth factor binding protein 3 (IGFBP3) was determined in the tissue lysates by ELISA. The expression of angiogenin was higher in early‑stage compared with late‑stage tumours (P=0.034) and the expression of IGFBP3 was higher in tumours compared with the metastatic lymph nodes (P=0.016). No statistically significant differences were recorded for VEGF, FGF, TIMP‑1 or IL‑8 between tumour stages or primary tumours and lymph nodes. To the best of our knowledge, this study was the first to investigate multiple angiogenic factors in the lysates of laryngeal carcinomas and metastatic nodes and identified angiogenin and IGFBP3 as factors possibly involved in tumour progression. A greater understanding of their function may offer novel prognostic and/or therapeutic options.

View Figures

View References

1.	Cooper JS, Porter K, Mallin K, et al: National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck. 31:748–758. 2009.PubMed/NCBI
2.	Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G and Maurizi M: Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer. 41:683–693. 2005. View Article : Google Scholar : PubMed/NCBI
3.	Krecicki T, Zalesska-Krecicka M, Jagas M, Szajowski K and Rak J: Laryngeal cancer in Lower Silesia: descriptive analysis of 501 cases. Oral Oncol. 34:377–380. 1998. View Article : Google Scholar : PubMed/NCBI
4.	Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
5.	Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995. View Article : Google Scholar : PubMed/NCBI
6.	Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
7.	Des Guetz G, Uzzan P, Nicolas P, et al: Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer. 94:1823–1832. 2006.PubMed/NCBI
8.	Beatrice F, Valente R, Cammarota R, et al: Laryngeal cancer and angiogenesis. Acta Otorhinolaryngol Ital. 16:355–362. 1996.
9.	Korampalli TS, Green VL, Greenman J and Stafford ND: Protein profiling of angiogenesis-related growth factors in laryngeal carcinoma: Pattern of protein expression in relation to tumour progression. Int J Oncol. 39:1033–1039. 2011.
10.	Bergers G and Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003. View Article : Google Scholar
11.	Chen Z, Malhotra PS, Thomas GR, et al: Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 5:1369–1379. 1999.PubMed/NCBI
12.	Ruokolainen H, Paakko P and Turpeenniemi-Hujanen T: Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Clin Cancer Res. 11:3257–3264. 2005. View Article : Google Scholar
13.	Gao X and Xu Z: Mechanisms of action of angiogenin. Acta Biochim Biophys Sin (Shanghai). 40:619–624. 2008. View Article : Google Scholar
14.	Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldeidge LA and Cheng L: Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res. 11:8358–8363. 2005. View Article : Google Scholar : PubMed/NCBI
15.	Marioni G, Marioni F, Blandamura S, et al: Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival. Histopathology. 57:535–543. 2010. View Article : Google Scholar
16.	Baxter RC: Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol. 54:145–148. 2001. View Article : Google Scholar : PubMed/NCBI
17.	Stewart CE and Rotwein P: Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev. 76:1005–1026. 1996.PubMed/NCBI
18.	Samani AA, Yakar S, LeRoith D and Brodt P: The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 28:20–47. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Pollak MN, Schernhammer ES and Hankinson SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer. 4:505–518. 2004. View Article : Google Scholar : PubMed/NCBI
20.	Ulanet DB, Ludwig DL, Kahn CR and Hanahan D: Insulin receptor functionally enhances multistage tumour progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci USA. 107:10791–10798. 2010. View Article : Google Scholar
21.	Wu X, Zhao H, Do KA, Johnson MM, Dong Q, Hong WK and Splitz MR: Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumours in patients with head and neck cancer. Clin Cancer Res. 10:3988–3995. 2004. View Article : Google Scholar
22.	Papadimitrakopoulou VA, Brown EN, Liu DD, El-Naggar AK, Jack Lee J, Hong WK and Lee HY: The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis. Cancer Lett. 239:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
23.	Shang ZJ, Li ZB and Li JR: VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies. Int J Oral Maxillofac Surg. 35:533–538. 2006. View Article : Google Scholar : PubMed/NCBI
24.	Ferrara N: Vascular endothelial growth factor. Eur J Cancer. 32A:2413–2422. 1996. View Article : Google Scholar : PubMed/NCBI
25.	Tae K, El-Naggar AK, Yoo E, et al: Expression of vascular endothelial growth factor and microvessel density in head and neck tumourigenesis. Clin Cancer Res. 6:2821–2828. 2000.PubMed/NCBI
26.	Bandoh N, Hayashi T, Takahara M, et al: VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis. Cancer Lett. 208:215–225. 2004. View Article : Google Scholar : PubMed/NCBI
27.	Sullu Y, Gun S, Atmaca S, Karagoz F and Kandemir B: Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx. Diagn Pathol. 5:352010. View Article : Google Scholar : PubMed/NCBI
28.	Li W, Wang C, Juhn SK, Ondrey FG and Lin J: Expression of fibroblast growth factor binding protein in head and neck cancer. Arch Otolaryngol Head Neck Surg. 135:896–901. 2009. View Article : Google Scholar : PubMed/NCBI
29.	Druzgal CH, Chen Z, Yeh NT, et al: A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck. 27:771–784. 2005. View Article : Google Scholar